Therapeutic Areas of Expertise
Southern Star Research supports biotech sponsors advancing new therapies through early clinical development.
We see our role as more than operational – we guide, educate, and advise throughout the trial lifecycle, often proposing solutions our clients haven’t yet considered. We bring deep therapeutic expertise, senior clinical teams, and Australia’s exceptional research environment together to give your programme the momentum it needs: from first-in-human through proof-of-concept and beyond.
Our programmes are built around a straightforward belief: sponsors should work with people who understand the science, not just the process. Every study we take on is managed by experienced professionals who know the indication, know the sites, and know how to keep things moving when complexity arises.
Australia’s Clinical Trials Notification (CTN) scheme decentralises regulatory review, compressing trial start-up by months compared to the US or EU.
One of the most important things we help sponsors understand is that when a study begins here, it genuinely begins – not placed in a queue. Our teams routinely achieve site initiation, site activation for screening, and first patient in screening at a pace that consistently delights sponsors accustomed to US or EU timelines.”
For sponsors preparing to scale, we bring experience collaborating alongside international CROs and global partners. Our systems, processes and data standards align with Phase 3 expectations, ensuring programmes initiated with us are well-positioned for seamless transition to later-phase, multi-country studies.
Our therapeutic areas
Our teams bring indication-specific expertise to each of the areas below: not just to run the study, but to inform protocol design, anticipate regulatory considerations, and help sponsors make better decisions earlier.
Select a therapeutic area below to explore our experience, indication depth and why Australia accelerates development in that field.
-
Central Nervous System
Read moreCNS clinical trials sit at the intersection of scientific rigour and operational precision.
-
Metabolic and Cardiovascular
Read moreMetabolic and cardiovascular conditions diabetes, obesity, and their downstream complications require clinical research that is as disciplined in execution as it is thoughtful in design.
-
Oncology and Immuno-Oncology
Read moreOncology is one of our most established and deeply embedded therapeutic areas.
-
Reproductive and Sexual Health
Read moreClinical research in reproductive and sexual health requires more than scientific competence.
-
Dermatology
Read moreDermatology trials sit at the intersection of clinical efficacy, visual assessment, and patient-reported outcomes.
-
Healthy Volunteer Studies
Read moreHealthy volunteer studies mark the start of human data collection the moment when years of preclinical work first meets a biological system.
-
Rare Diseases and Unmet Conditions
Read morePatient populations are small, often geographically dispersed, and living with conditions for which treatment options may be limited or absent. In this context, delays are not inconveniences they are barriers to treatment for people who cannot wait.
-
Vaccines and Infectious Diseases
Read moreVaccine and infectious disease trials demand speed, scientific precision, and careful risk management particularly in early-phase development where safety, immunogenicity, and proof-of-concept data are foundational to what follows.
Speak with a team member
Explore how our expertise and Australia’s clinical advantages can support your next Phase 1 or Phase 2 study.
